Microbial Sequencing Solutions in Various Applications

We apply high-throughput sequencing (Illumina MiSeq/HiSeq, PacBio SMRT sequencing, Nanopore sequencing) to analyze the diversity of oral, intestinal, skin, vaginal, fecal, blood, and other microbiomes, allowing researchers to gain insight into the relationship between oral microbes and human health.

Next-generation sequencing (NGS) is emerging as a powerful method that allows researchers to analyze the diversity of microbial communities in environmental samples such as water, soil, and air, providing insight and accuracy into the molecular level of environmental complexity.

We are committed to supporting our customers' research and practice on animal health and productivity with a range of microbial genomics solutions. We have extensive expertise to handle all types of agricultural microbiome samples from stool, rumen, meat product, breeding environments and so on.

Our microbial genomics services are dedicated to supporting the drug discovery process from discovery to market. Main research interests: drug target discovery, microbial therapeutics and biomarker discovery.

CD Genomics is dedicated to providing reliable and affordable microbial sequencing and research services for pharmaceutical, veterinary drug, food & beverage, and cosmetic industries.

We provide advanced genomics methods to explore the microbial diversity and structure of biofilm samples, and discover previously undetected microbial species and predict their roles in biofilm formation, human health or environments.

We use next-generation sequencing, third-generation high-throughput sequencing, and other methods to measure the DNA of microorganisms in the sample, and process large amounts of data through bioinformatics analysis to reveal the types of microorganisms, the relative abundance, evolutionary relationship, and to provide analysis of functional characterization and pathways.